Home Hospital for Lymphoma

Mass General Brigham

Status: Terminated

Conditions: Lymphoma

Treatments: Other: Home Hospital for Lymphoma

Study type: Interventional

Funder types: Other

Identifiers

NCT04423848

19-613

Details and patient eligibility

About

The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.

Full description

This research study is a single arm pilot Feasibility Study, which is the first-time investigators are examining this hospital at home intervention for patients with lymphoma.

The research study procedures include screening for eligibility, questionnaires, remote patient monitoring (e.g. patient-reported symptoms and home monitored vital signs) and home-based supportive care (e.g. visits to patients' homes to address and manage any concerning issues identified), and interviews of participants, caregivers, and clinicians asking their perceptions of the Home Hospital for Lymphoma program.

Participants will include 3 groups:

Enrolled participants receiving the hospital at home intervention, caregivers of participants, and clinicians.

Participants will be in the research study for about six months after consent. It is expected that up to 38 participants will take part in this research study.

Enrollment: 3 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 or older
• Receiving their lymphoma care with curative intent at MGH (treatment intent based upon chemotherapy order in the electronic medical record)
• Hemodynamically stable during the first 24 hours of hospital admission at MGH
• Residing within the designated geographic area for MGH Home Hospital Service (an approximately 10-mile radius from MGH)
• Able to communicate and respond to questionnaires in English
• Lives with a family member or a friend who supports the patient at home
• Deemed eligible for supportive oncology care at home based on the MGH Home Hospital clinician evaluation

Exclusion criteria

• Those admitted to the intensive care unit
• Have high oxygen requirement (FIO2 > 0.4)
• Experience active angina or cardiac arrythmias
• Have a planned inpatient surgical or interventional procedure
• Have uncontrolled psychiatric illness or impaired cognition that prohibits complying with the study procedures
• Have uncontrolled pain requiring intravenous pain medications
• Those deemed ineligible based on the Home Hospital Service clinician evaluation

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

3 participants in 1 patient group

Home Hospital for Lymphoma

Experimental group

Description:

The Home Hospital for Lymphoma intervention entails the following: patient-reported symptoms and vital signs with appropriate triggers for phone calls and home visits, and regular communication with oncology clinicians regarding care delivered at home to ensure continuity of care.

Treatment:

Other: Home Hospital for Lymphoma